Fusion, the university IP commercialisation company that turns university IP into business, is pleased

to announce that Phase Focus, its Sheffield?based microscopy company, has raised £370,000 to help

take the company through to its first commercial deals.

The investment round comprised: Fusion (£175,000), White Rose Technology Seedcorn Fund

(£175,000), and The Viking Fund (£20,000). Post funding Fusion owns a 54.2% stake in Phase Focus.

The Phase Focus Virtual Lens® eliminates the need for high?quality lenses in microscopes by

transferring the image?producing step to a computer programme. This disruptive innovation is

expected to revolutionise microscopy, not only by eliminating the restrictions and performance

limitations of today’s conventional focussing devices, but also by enabling a range of new capabilities

including post?acquisition focussing and high?contrast stain?free imaging.

The Virtual Lens has been demonstrated in all three of the Company’s initially targeted wavelength

regimes (optical, electron and X?ray microscopy.) This new funding will enable the Company to

further develop its Virtual Lens product, and to solidify relationships with key OEM’s in the $2.2

billion laboratory R&D microscopy market, the $700 million cellular assays market, and the $2.1

billion semiconductor metrology market.

David Baynes, CEO of Fusion said:

“Phase Focus continues to excite us. This is a world leading disruptive technology that continues to

have the potential to revolutionise the huge global microscopy market.”